<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are a subgroup of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with a low-grade <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>They are characterized by a frequent chromosome abnormality, a translocation between chromosome 14 and chromosome 18 </plain></SENT>
<SENT sid="2" pm="."><plain>This translocation plays a role in the development of this disease </plain></SENT>
<SENT sid="3" pm="."><plain>The course of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is slow, usually lasting several years but is ultimately fatal, Their treatment is controversial </plain></SENT>
<SENT sid="4" pm="."><plain>Recently, an association of chemotherapy and alpha interferon appeared promising </plain></SENT>
<SENT sid="5" pm="."><plain>Other drugs such as fludarabine or 2' chlorodeoxyadenosine are currently tested </plain></SENT>
</text></document>